DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Celgene (NASDAQ: CELG)

94.76 -0.21 (-0.22%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $94.76 -0.22%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $94.93
Previous Close $94.97
Daily Range $93.82 - $96.85
52-Week Range $66.85 - $96.85
Market Cap $75.8B
P/E Ratio 54.90
Dividend (Yield) $0.00 (0.0%)
Volume 8,706,941
Average Daily Volume 5,160,182
Current FY EPS $3.20

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

3 Biotech Stocks Near 52-Week Highs Worth Selling

Three Motley Fool analysts weigh in on which stocks they think should be sold near their highs.

Earnings Scheduled For October 23, 2014

Pre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, P

Pre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, PCP, RTN, POT

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst B

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog

UPDATE: Credit Suisse Reiterates On Celgene On Increased Peak Sales Estimates

Celgene Corporation's Earnings Preview: Pay Attention to New Kids

Revlimid might be the flagship, but growth will come from the newer drugs.

Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog

Watch For Today's Momo Momentum Stock: Celgene (CELG)

3 Stocks Reiterated As A Buy: PFE, MU, CELG

First Detailed Look at Celgene Crohn's Disease Pill Impresses

See More CELG News...

CELG's Top Competitors

CELG $94.76 (-0.22%)
Current stock: CELG
AMGN $143.64 (-0.31%)
Current stock: AMGN
GILD $106.09 (-0.54%)
Current stock: GILD
$0.00 (0.00%)
Current stock: